TS2323027198	treatedDisease 61 83	acute myeloid leukemia
TS2423027198	treatedDisease 87 111	myelodysplastic syndrome
TS1423027198	drug 132 166	broad-spectrum triazole antifungal
TS1223027198	treatedDisease 588 610	acute myeloid leukemia
TS2123027198	treatedDisease 614 638	myelodysplastic syndrome
TS823027198	treatedDisease 789 815	gastrointestinal disorders
TS723027198	food 863 885	caloric and fat intake
TS1923027198	treatedDisease 1055 1064	mucositis
TS623027198	treatedDisease 1087 1093	nausea
TS1523027198	treatedDisease 1109 1117	diarrhea
TS2023027198	treatedDisease 1136 1144	vomiting
TS1323027198	food 1257 1267	fat intake
TS323027198	drug 1331 1353	proton pump inhibitors
TS1723027198	drug 1405 1415	tacrolimus
TS123027198	drug 1555 1565	tacrolimus
TS523027198	treatedDisease 1604 1613	mucositis
TS223027198	food 1633 1637	food
TS1823027198	drugEffect 1717 1732	bioavailability
TS923027198	treatedDisease 1773 1799	gastrointestinal disorders
TS2223027198	food 1802 1806	food
T1	drug 31 43	posaconazole
T2	drug 114 126	Posaconazole
T3	modeadm 183 187	oral
T4	drug 258 270	posaconazole
T5	drug 571 583	posaconazole
T6	numbers 529 531	40
R1	treat Arg1:T5 Arg2:TS1223027198	
R2	treat Arg1:T5 Arg2:TS2123027198	
T7	food 1196 1217	higher caloric intake
T8	sideeffect 1354 1372	decreased the PPCs
R3	has_sideeffect Arg1:TS323027198 Arg2:T8	
T9	sideeffect 1416 1433	increased the PPC
R4	has_sideeffect Arg1:TS1723027198 Arg2:T9	
T10	sideeffect 1492 1512	influencing the PPCs
R5	has_sideeffect Arg1:TS123027198 Arg2:T10	
R6	relation Arg1:TS223027198 Arg2:T10	
T11	drug 1704 1716	posaconazole
R7	relation Arg1:TS2223027198 Arg2:T11	
